参考文献/References:
1 Nagase HV, Murphy G. Structure and function of matrix metalloproteinases and TIMPs [J]. Cardiovasc Res, 2006, 69(3): 562-573.
2 Xue MT, Jackson CJ. Targeting matrix metalloproteases to improve cutaneous wound healing [J]. Expert OpinTher Targets, 2006, 10(1): 143-155.
3 Ortega N, Behonick D, Stickens D, et al. How proteases regulate bone morphogenesis [J]. 2003, 995: 109-116.
4 Fernandez-Catalan C, Bode W, Huber R, et al. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor [J]. EMBO J, 1998, 17(17): 5238-5248.
5 Gomis-Rüth FX, Maskos K, Betz M, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1 [J]. Nature, 1997, 389(6646): 77-81.
6 Van Lint P, Libert C. Matrix metalloproteinase-8: cleavage can be decisive [J]. Cytokine Growth Factor Rev, 2006, 17(4): 217-223.
7 Pandruvada SN, Gonzalez OA, Kirakodu S, et al. Bone biology-related gingival transcriptome in ageing and periodontitis in non-human primates [J]. J ClinPeriodontol, 2016, 43(5): 408-417.
8 Mittag F, Falkenberg EM, Janczyk A, et al. Laminin-5 and type I collagen promote adhesion and osteogenic differentiation of animal serum-free expanded human mesenchymal stromal cells [J]. Orthop Rev (Pavia), 2012, 4(4): e36.
9 Salasznyk RM, Klees RF, Boskey A, et al. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5 [J]. J Cell Biochem, 2007, 100(2): 499-514.
10 Grzibovskis M, Urtane I, Pilmane M, et al.Specific signaling molecule expressions in the interradicular septum in different age groups [J]. Stomatologija, 2011, 13(3): 81-86.
11 Syggelos SA, Aletras AJ, Smirlaki I, et al. Extracellular matrix degradation and tissue remodeling in periprosthetic loosening and osteolysis:focus on matrix metalloproteinases,their endogenous tissue inhibitors,and the proteasome [J]. 2013: 230805.
12 Hsu SM, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics [J]. Am J ClinPathol, 1981, 75(6): 816-821.
13 Hasty KA, Jeffrey JJ, Hibbs MS, et al. The collagen substrate specificity of human neutrophil collagenase [J]. J BiolChem, 1987, 262(21): 10048-10052.
14 Morgan AR, Han DY, Lam WJ, et al. Genetic variations in matrix metalloproteinases May be associated with increased risk of ulcerative colitis [J]. Hum Immunol, 2011, 72(11): 1117-1127.
15 Du JL, Jin TB, Cao YJ, et al. Association between genetic polymorphisms of MMP8 and the risk of steroid-induced osteonecrosis of the femoral head in the population of northern China [J]. Medicine (Baltimore), 2016, 95(37): e4794.
16 Chen JY, Liu WL, Cao YJ, et al. MMP-3 and MMP-8 single-nucleotide polymorphisms are related to alcohol-induced osteonecrosis of the femoral head in Chinese males [J]. Oncotarget, 2017, 8(15): 25177-25188.
17 Itoh T, Matsuda H, Tanioka M, et al. The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis [J]. J Immunol, 2002, 169(5): 2643-2647.
18 Kusano K, Miyaura C, Inada M, et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption [J]. Endocrinology, 1998, 139(3): 1338-1345.
19 Lorenzo JA, Pilbeam CC, Kalinowski JF, et al. Production of both 92-and 72-kDa gelatinases by bone cells [J]. Matrix, 1992, 12(4): 282-290.
20 Wittrant Y, Theoleyre S, Couillaud S, et al. Regulation of osteoclast protease expression by RANKL [J]. BiochemBiophys Res Commun, 2003, 310(3): 774-778.
21 Fujisaki K, Tanabe N, Suzuki N, et al. Receptor activator of NF-kappa B ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells [J]. Life Sci, 2007, 80(14): 1311-1318.
22 Am?linei C, C?runtu ID, Giu?c? SE, et al. Matrix metalloproteinases involvement in pathologic conditions [J]. RomJMorpholEmbryol, 2010, 51(2): 215-228.
23 Beeh KM, Beier J, Kornmann O, et al. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects [J]. Respir Med, 2003, 97(6): 634-639.
24 Jiménez-Morales S, Martínez-Aguilar N, Gamboa-Becerra R, et al. Polymorphisms in metalloproteinase-9 are associated with the risk for asthma in Mexican pediatric patients [J]. Hum Immunol, 2013, 74(8): 998-1002.
25 Nakashima K, Hirota T, Obara K, et al. A functional polymorphism in MMP-9 is associated with childhood atopic asthma [J]. BiochemBiophys Res Commun, 2006, 344(1): 300-307.
26 Feng ZT, He GC, Chen ZH, et al. Lack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis [J]. BMC MusculoskeletDisord, 2014, 15: 376.
27 Williams RO, Feldmann M, Maini RN. Cartilage destruction and bone erosion in arthritis:the role of tumour necrosis factor alpha [J]. Ann Rheum Dis, 2000, 59(Suppl): 75-80.
28 Adiguzel M, Horozoglu C, Kilicoglu O, et al. MMP-3 gene polymorphisms and Osteosarcoma [J]. Indian J ExpBiol, 2016, 54(3): 175-179.
29 Juran BD, Atkinson EJ, Schlicht EM, et al. Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis [J]. Liver Int, 2011, 31(6): 787-793.
30 Slattery ML, John E, Torres-Mejia GA, et al. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the breast cancer health disparities study [J]. PLoS One, 2013, 8(5): e63165.
31 Ling Y, Peng C, Liu C, et al. Gene polymorphism of IL-6 and MMP-3 decreases passive range of motion after rotator cuff repair [J]. Int J ClinExpPathol, 2015, 8(5): 5709-5714.